https://www.selleckchem.com/pr....oducts/polyinosinic-
First-line treatment of Parkinson's disease (PD) includes a dopamine analog, levodopa, administered in combination with carbidopa to increase efficacy. Wearing-off (WO) phenomenon is a frequent complication which is defined as a reoccurrence of motor and non-motor symptoms during levodopa free interval, which has a negative impact on the quality of life of patients. Through this study, we aim to determine risk factors that leadto the manifestation of the WO phenomenon among patients presenting in our out-pat
Like
Comment
Share
